Development of an Activatable Fluorescent Probe for Prostate Cancer Imaging
Authors:
- Takao YogoTYTakao Yogo
- Keitaro UmezawaKUKeitaro Umezawa
- Rumi HinoRHRumi Hino
- Yasuteru UranoYUYasuteru Urano
- 26 July 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 28 (8) , 2069-2076
Abstract
Technology to visualize small prostate cancers is urgently needed because of the difficulty of discriminating prostate cancer from normal tissue with the naked eye, and a fluorescence imaging method would be advantageous. Here, we describe the design and synthesis of a fluorogenic probe (Ac–KQLR–HMRG) that is activated by hepsin and matriptase (proteases over-expressed in prostate cancer). Ac–KQLR–HMRG exhibited significant turn-on fluorogenicity in the presence of hepsin (180-fold) and matriptase (80-fold) and allowed specific fluorescence imaging of various prostate cancer cell line in vitro. In addition, the probe enabled rapid imaging (within 1–10 min) of small prostate cancer nodules in mouse models of disseminated peritoneal tumor and orthotopic tumor.Keywords
Funding Information
- Core Research for Evolutional Science and Technology
- Precursory Research for Embryonic Science and Technology
- Japan Agency for Medical Research and Development
- Japan Foundation for Applied Enzymology
- Japan Society for the Promotion of Science (JP15H05951, JP16H02606, JP26111012)
- Hoansha Foundation
This publication has 37 references indexed in Scilit:
- Fluorescence-guided surgery with live molecular navigation — a new cutting edgeNature Reviews Cancer, 2013
- Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical ProstatectomyEuropean Urology, 2012
- Radical Prostatectomy versus Observation for Localized Prostate CancerNew England Journal of Medicine, 2012
- Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent ProbeScience Translational Medicine, 2011
- Targeted, Activatable, In Vivo Fluorescence Imaging of Prostate-Specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody–Indocyanine Green (ICG) ConjugateBioconjugate Chemistry, 2011
- Tumor Detection by Imaging Proteolytic ActivityCancer Research, 2010
- Detection of Early Prostate Cancer Using a Hepsin-Targeted Imaging AgentCancer Research, 2008
- Use of multiple biomarkers for a molecular diagnosis of prostate cancerInternational Journal of Cancer, 2004
- Hepsin promotes prostate cancer progression and metastasisCancer Cell, 2004
- Delineation of prognostic biomarkers in prostate cancerNature, 2001